Trial Profile
A Retrospective,48 month study comparing long term impact of uninterrupted Ivabradine treatment with beta blockers on persistent tachycardia in patients with Lung cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Sinus tachycardia
- Focus Adverse reactions; Therapeutic Use
- 22 Nov 2016 New trial record